Company Encyclopedia
View More
name
UNIV
301166.SZ
Shanghai Universal Biotech Co.,Ltd. distributes and supplies antibodies and protein products. The company offers antibodies, recombinant proteins, detection kits, antigens, and other products, as well as immunology reagents, molecular biology reagents, cell biology reagents and biochemical reagents. It also provides technical services, technology promotion, technology information exchange, scientific and technology training, technology consulting, technology incubation and other services, as well as experimental services and software solutions.
398.24 B
301166.SZMarket value -Rank by Market Cap -/-

Financial Score

24/12/2025 Update
C
Health Care DistributorsIndustry
Industry Ranking21/25
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-0.93%D
    • Profit Margin-1.78%D
    • Gross Margin19.74%D
  • Growth ScoreD
    • Revenue YoY-8.67%D
    • Net Profit YoY-234.66%E
    • Total Assets YoY-3.10%D
    • Net Assets YoY-2.52%D
  • Cash ScoreE
    • Cash Flow Margin-5608.16%E
    • OCF YoY-8.67%D
  • Operating ScoreC
    • Turnover0.47C
  • Debt ScoreA
    • Gearing Ratio8.89%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    UNIV released its performance for the first three quarters, with a net loss attributable to the parent company of 15.0796 million yuan

    According to the Zhitong Finance APP, UNIV released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 776 million yuan, a year-on-year decrease of 6.24%. The net loss attributable to shareholders of the listed company was 15.0796 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 30.2745 million yuan. The basic loss per share was 0.17 yuan

    Zhitong·
    SZ
    301166
    +0.60%
    Zhitong·
    SZ
    301166
    +0.60%

    UNIV: As of August 31, 2025, the company has not yet implemented this share repurchase

    UNIV announced that as of August 31, 2025, the company has repurchased a total of 0 shares through a dedicated securities account for share repurchase via centralized bidding, accounting for 0% of the company's total share capital. The company has not yet implemented this share repurchase. This share repurchase complies with relevant laws, administrative regulations, normative documents, and the company's share repurchase plan

    Zhitong·
    SZ
    301166
    +0.60%
    Zhitong·
    SZ
    301166
    +0.60%

    UNIV released its half-year performance, turning from profit to a loss of 13.3799 million yuan

    According to the Zhitong Finance APP, UNIV released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 505 million yuan, a year-on-year decrease of 8.63%. The net loss attributable to shareholders of the listed company was 13.3799 million yuan. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 20.6835 million yuan. The basic loss per share was 0.15 yuan

    Zhitong·
    SZ
    301166
    +0.60%
    Zhitong·
    SZ
    301166
    +0.60%

    UNIV's 45.3978 million restricted shares will be listed and circulated on June 30

    According to the Zhitong Finance APP, UNIV announced that the number of shares to be released from restrictions prior to its initial public offering is 45.3978 million shares, accounting for 52.38% of the total share capital after the company's issuance. The listing and circulation date is postponed to June 30, 2025 (Monday)

    Zhitong·
    SZ
    301166
    +0.60%
    Zhitong·
    SZ
    301166
    +0.60%

    UNIV was reduced by 1.41% of shares by shareholders Taili Investment and Hentai Investment

    According to the Zhitong Finance APP, UNIV announced that its shareholder Shanghai Chuangye Jieli Taili Venture Capital Center (Limited Partnership) (referred to as "Taili Investment") and its concerted party Shanghai Taili Venture Capital Management Co., Ltd. - Shanghai Hantai Venture Capital Partnership (Limited Partnership) (referred to as "Hantai Investment") collectively reduced their holdings in the company by 1.2085 million shares through centralized bidding and block trading, accounting for 1.41% of the total share capital of the company after deducting the shares in the repurchase special account

    Zhitong·
    SZ
    301166
    +0.60%
    Zhitong·
    SZ
    301166
    +0.60%
    © 2025 Longbridge｜Disclaimer